Outcomes based on Fistpatrick Skin Type (FST): Kaplan-Meier Analysis
| Characteristic |
Death
|
Recurrence
|
Enucleation
|
Metastasis
|
| Event N |
HR |
95% CI |
p-value |
Event N |
HR |
95% CI |
p-value |
Event N |
HR |
95% CI |
p-value |
Event N |
HR |
95% CI |
p-value |
| 24 Months |
| FST |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FST I |
3 |
— |
— |
|
1 |
— |
— |
|
1 |
— |
— |
|
12 |
— |
— |
|
| FST II |
6 |
1.17 |
0.26, 5.29 |
0.8 |
10 |
0.63 |
0.07, 5.46 |
0.7 |
11 |
1.06 |
0.13, 8.76 |
>0.9 |
51 |
0.89 |
0.46, 1.69 |
0.7 |
| FST III-V |
1 |
3.07 |
0.26, 35.8 |
0.4 |
1 |
0.49 |
0.03, 8.68 |
0.6 |
2 |
0.65 |
0.06, 7.54 |
0.7 |
5 |
2.25 |
0.78, 6.53 |
0.13 |
| 36 Months |
| FST |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FST I |
6 |
— |
— |
|
2 |
— |
— |
|
1 |
— |
— |
|
15 |
— |
— |
|
| FST II |
12 |
0.45 |
0.14, 1.42 |
0.2 |
11 |
1.54 |
0.33, 7.27 |
0.6 |
12 |
0.89 |
0.11, 7.34 |
>0.9 |
77 |
0.95 |
0.53, 1.69 |
0.9 |
| FST III-V |
1 |
3.96 |
0.39, 40.4 |
0.2 |
1 |
1.49 |
0.12, 17.9 |
0.8 |
2 |
0.68 |
0.06, 7.81 |
0.8 |
7 |
0.96 |
0.38, 2.40 |
>0.9 |
| 48 Months |
| FST |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FST I |
6 |
— |
— |
|
3 |
— |
— |
|
1 |
— |
— |
|
18 |
— |
— |
|
| FST II |
17 |
0.29 |
0.09, 0.91 |
0.035 |
15 |
1.20 |
0.34, 4.24 |
0.8 |
16 |
0.54 |
0.07, 4.43 |
0.6 |
80 |
1.24 |
0.74, 2.09 |
0.4 |
| FST III-V |
1 |
3.79 |
0.37, 38.4 |
0.3 |
2 |
1.10 |
0.18, 6.74 |
>0.9 |
4 |
0.40 |
0.04, 3.86 |
0.4 |
11 |
0.55 |
0.25, 1.20 |
0.13 |
| 60 Months |
| FST |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FST I |
9 |
— |
— |
|
3 |
— |
— |
|
1 |
— |
— |
|
20 |
— |
— |
|
| FST II |
20 |
1.23 |
0.53, 2.83 |
0.6 |
15 |
1.20 |
0.34, 4.24 |
0.8 |
16 |
0.57 |
0.07, 4.65 |
0.6 |
88 |
1.07 |
0.65, 1.74 |
0.8 |
| FST III-V |
2 |
0.29 |
0.04, 2.39 |
0.3 |
2 |
1.10 |
0.18, 6.74 |
>0.9 |
5 |
0.25 |
0.03, 2.48 |
0.2 |
12 |
0.72 |
0.35, 1.48 |
0.4 |
| 84 Months |
| FST |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FST I |
9 |
— |
— |
|
3 |
— |
— |
|
2 |
— |
— |
|
23 |
— |
— |
|
| FST II |
25 |
0.60 |
0.27, 1.33 |
0.2 |
19 |
0.72 |
0.21, 2.55 |
0.6 |
17 |
1.97 |
0.43, 8.93 |
0.4 |
98 |
1.06 |
0.67, 1.68 |
0.8 |
| FST III-V |
3 |
0.35 |
0.09, 1.39 |
0.14 |
2 |
1.04 |
0.17, 6.33 |
>0.9 |
5 |
1.36 |
0.25, 7.35 |
0.7 |
12 |
1.07 |
0.53, 2.16 |
0.8 |
| 120 Months |
| FST |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FST I |
10 |
— |
— |
|
3 |
— |
— |
|
2 |
— |
— |
|
23 |
— |
— |
|
| FST II |
26 |
1.05 |
0.48, 2.29 |
>0.9 |
20 |
0.66 |
0.19, 2.33 |
0.5 |
17 |
1.97 |
0.43, 8.93 |
0.4 |
102 |
0.94 |
0.59, 1.48 |
0.8 |
| FST III-V |
4 |
0.52 |
0.16, 1.72 |
0.3 |
2 |
1.04 |
0.17, 6.29 |
>0.9 |
5 |
1.36 |
0.25, 7.35 |
0.7 |
13 |
0.84 |
0.42, 1.67 |
0.6 |